RESOURCES | Content | Blog Posts

CRB Monitor-Refinitiv Partnership and Product Launch!
Published on November 24, 2020


CRB Monitor is excited to announce a new data partnership with Refinitiv!

Serving more than 40,000 institutions in approximately 190 countries, Refinitiv provides information, insights and technology that drive innovation and performance in global financial markets.

CRB Monitor's best-in-class marijuana-related business data can now be accessed through Refinitiv's industry-leading World-Check® platform and will be referred to as MRB Check (Powered by CRB Monitor). MRB Check provides CRB Monitor's robust corporate intelligence on "Tier1" (aka “Direct”) marijuana-related businesses (MRBs) operating in the U.S. and Canada, including insight into licensing and beneficial owners. The solution enables institutions to more effectively identify and manage marijuana-related risks and opportunities.

MRB Check (Powered by CRB Monitor) data is available for download from the World-Check® Data File system, using the same download formats, protocols and structure as the World-Check files:
  • Uses https and sftp download protocols
  • Formats: XML and CSV and include MD5 check sums
  • Daily, Weekly, Monthly and Full download periods are available
  • Access using your existing Data File login credentials
For more details, see the MRB Check (Powered by CRB Monitor) brochure.


Learn More During the Product Launch Webinar

In honor of this new partnership, CRB Monitor's CEO and Founder, Steve Kemmerling will be teaming-up with Refinitiv's Holly Sais Phillippi, Head of Risk Proposition Sales, to host a product launch webinar.

Webinar Details

Date:              Wednesday, December 2, 2020
Time:              2:00 PM ET | 1:00 PM CT | 11:00 AM PT
Topic:             MRB Check: Screening for Marijuana-Related Risk and Relationships
Presenters:   Steve Kemmerling, CRB Monitor & Holly Seis Phillippi, Refinitiv
 
MRB Check webinar

Most Popular

Subscribe For Updates

Explore how CRBMonitor can simplify your cannabis-related compliance challenges.